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The role of oxytocin (OT) in the regulation of prostaglandin F2a (PGF2a ) secre-
tion during luteolysis in gilts was studied using a highly specific OT antagonist (CAP-
581). In Experiment 1 gilts on Days 14 to 19 of the oestrous cycle in Latin square de-
sign were used, to determine the dose and time of application of OT and CAP. In
Group I (n = 6) gilts were treated intravenously with saline or with 10, 20 and 30 IU of
OT. Concentrations of the main PGF2a metabolite i.e. 13,14-dihydro-15-keto-prosta-
glandin F2a (PGFM) were measured in blood samples as uterine response to the treat-
ment. Twenty IU of OT was the most effective to stimulate PGFM release and this dose
was used after CAP treatment in gilts of Groups II, III and IV. Gilts of Group II (n = 3)
were injected into the uterine horns (UH) with saline (5 ml/horn) or CAP (2 mg, 3 mg
and 4 mg; half dose/horn) and OT was injected (i.v.) 30 min thereafter. Any of the CAP
doses given into the UH affected PGFM plasma concentrations stimulated by OT. In
Group III (n = 4) gilts were infused (i.v.) for 30 min with CAP (9 mg, 14 mg and
18mg/gilt) followed by 20 IU of OT. All doses of CAP effectively inhibited OT-
stimulated PGF2a release, therefore 9 mg was selected for the further studies. Gilts of
Group IV (n = 4) received OT 4, 6 and 8 h after CAP to define how long CAP blocks
the OT receptors. Concentrations of PGFM increased after any of this period of time.
Thus, we concluded that 9 mg of CAP infused every 4 h will effectively block OT re-
ceptors. In Experiment 2, gilts (n = 4) received CAP as a 30-min infusion every 4 h on
Days 1220 of the oestrous cycle. Control gilts (n = 3) were infused with saline. CAP
infusions diminished the height of PGFM peaks (P < 0.05). Frequency of the PGFM
(P < 0.057) and OT (P < 0.082) peaks only tended to be lower in the CAP-treated gilts.
Peripheral plasma concentrations of progesterone (P4) and oestradiol-17b (E2) and the
time of luteolysis initiation as measured by the decrease of P4 concentration were the
same in CAP- and saline-treated gilts. The macroscopic studies of the ovaries in gilts
revealed lack of differences between groups. We conclude that OT is involved in the
secretion of luteolytic PGF2a peaks but its role is limited to controlling their height and
frequency. Blocking of OT receptors did not prevent luteolysis in sows.
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Prostaglandin F2a (PGF2a) of uterine origin is suggested to be necessary for
luteal regression in sows (Gleeson et al., 1974; Moeljono et al., 1977). OT is as-
sumed to be involved in the regulation of PGF2a secretion at luteolysis (Kotwica et
al., 1990; Mirando et al., 1996). (i) Treatment of sows with OT during late but not
at early and mid-cycle increases PGF2a secretion and largest OT responsiveness is
at luteolysis (Kieborz et al., 1991; Carnahan et al., 1996; Edgerton et al., 1996). (ii)
OT acts through the specific OT receptors the concentration of which is low in the
endometrium during the early and mid-luteal phase, with a tendency to increase
around luteolysis and it is the highest at oestrus (Whiteaker et al., 1994; Okano et
al., 1996). However, increase of responsiveness to OT and subsequent PGF2a se-
cretion is weakly associated with changes in OT receptor numbers but it is strongly
connected with coupling of OT receptors to Gq protein and their affinity to the li-
gand (Ludwig et al., 1998). (iii) Intracellular signalling pathway from the OT re-
ceptors depends on stimulation of phospholipase C activity to initiate phospho-
inositide (PI) hydrolysis and formation of second messengers  inositol triphos-
phate (IP3) and presumably diacylglycerol (DAG) (Whiteaker et al., 1995; Tyssel-
ing et al., 1996). In in vitro studies stimulation of endometrial PI hydrolysis by OT
is positively correlated with PGF2a release (Mirando et al., 1995; Whiteaker et al.,
1995). Since PGF2a and its metabolite PGFM are released during luteolysis in a
pulsatile manner (Gleeson et al., 1974; Moeljono et al., 1977; Shille et al., 1979),
the role of OT in the control of PGF2a peaks secretion is possible, but this mecha-
nism is unknown. Moreover, only pharmacological doses of OT, both in in vitro
and in vivo experiments, are able to stimulate PGF2a release in cyclic sows
(Kieborz et al., 1991; Whiteaker et al., 1995). Thus, to assess the role of OT in
PGF2a release and the course of luteolysis, OT receptors were blocked by the con-
tinuous treatment of cyclic gilts with CAP, an OT antagonist (1-deamino-2-D-
Tyr(Oet)-4-Thr-8-Orn-oxytocin, Ferring AB, Sweden). CAP binds directly to OT
receptors and blocks PI hydrolysis (Lopez-Bernal et al., 1989; Melin, 1993).
Materials and methods
Animals and surgical procedure
Twenty-four gilts (103 ± 4.0 kg) during their second or third oestrous cy-
cle were used in this study; 17 and 7 animals in Experiment 1 and Experiment 2,
respectively. Four days before the experiments, polyvinyl chloride catheters
were inserted into the right and left jugular veins (JV) in all gilts under general
anaesthesia with pentabarbitone sodium (12 mg/kg b.w.) (Kotwica et al., 1978).
Additionally, both uterine horns were cannulated in three gilts of Experiment 1
for saline and CAP infusions (Schneider et al., 1983). In the remaining gilts sa-
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line, OT or CAP were given throughout the right JV cannulae. Blood samples
were collected from the left vessel without restraining the animals.
Experiment 1
On Days 1419 of the oestrous cycle gilts (n = 17) were used to establish the
dose and way of the CAP infusion which would effectively block the function of OT
receptors in the uterus. Gilts in the groups were treated in Latin square design. In
Group I (n = 6) saline (2 ml) or OT (10 IU, 20 IU and 30 IU) were given intrave-
nously (i.v.). In Group II (n = 3) saline (5 ml/horn) or CAP (2 mg, 3 mg and 4 mg)
were injected into the uterine horns (the half dose/horn) and OT (20 IU) in bolus
(i.v.) injection was given 30 min thereafter. In Group III (n = 4) CAP (9 mg, 14 mg
and 18 mg/gilt) was infused for 30 min i.v. and OT (20 IU) in bolus injection was
given immediately thereafter, while in Group IV (n = 4) CAP (9 mg) was given as in
Group III and OT (20 IU) was injected 4 h, 6 h and 8 h after infusion of CAP, which
was always dissolved in 10 ml of saline, 30 min before its infusion. Blood samples
(6 ml) were taken every 10 min for 1 h before OT injection and every 5 to 20 min for
1 h after that. In Group III blood samples were collected every 5 to 10 min for two
3-h periods during saline or CAP infusions. Concentrations of PGFM were measured
in plasma samples as uterine response to OT treatment.
Experiment 2
The model of CAP infusion established in Experiment 1 was applied in
Experiment 2. Gilts (n = 4) were infused (i.v.) with 9 mg of CAP in 10 ml of sa-
line for 30 min every 4 h from Day 12 to Day 20 of the oestrous cycle. Control
gilts (n = 3) received saline in the same way. Blood samples were collected
every hour during the experiment, starting four hours before the first infusion.
Concentrations of PGFM, OT, progesterone and oestradiol-17 b were deter-
mined in blood samples. For macroscopic examination of the ovaries, gilts were
slaughtered in the local slaughterhouse on the third and fourth day following the
last infusion.
Hormone analysis
Concentrations of hormone were determined by RIA described for proges-
terone (P4) and oestradiol-17 b (E2) (Hotchkiss et al., 1971), OT (Schams et al.,
1979) and PGFM (Homanics and Silvia, 1988). The specificity of the antibodies
used was given earlier: for P4 (Dziadkowiec et al., 1982), E2 (Szafranska and Til-
ton, 1993), OT (Kotwica and Skarzynski, 1993) and PGFM (Homanics and Silvia,
1988). OT antibodies used in our study did not cross-react with CAP. Efficiency of
extraction for E2 and OT was 89.0 ± 1.1 and 85.0 ± 0.8%, respectively. Final data
were corrected for the procedural losses. The sensitivity of the assay was: P4 
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0.1 ng/ml, E2  2.5 pg/ml, OT  3 pg/ml and PGFM  60 pg/ml. The coefficient of
correlation (r) between added and recovered amounts of different hormone con-
centrations (24 concentrations in blank plasma) were: P4  0.991, E2  0.988, OT
 0.836 and PGFM  0.992. The intra- and interassay CVs were: P4  6.9% and
8%, E2  8.9% and 12.3%, OT  8.6% and 14% and PGFM  4.2% and 6.0%.
Statistical analysis
The baselines for PGFM in Experiment 1 were calculated on the basis of
its seven determinations before OT or saline treatment and then compared by t-
test with the post-treatment PGFM concentrations. The peaks for OT and PGFM
in Experiment 2 were defined when any 3 consecutive concentrations of hor-
mones exceeded the baselines by 50%. The baselines of hormones were calcu-
lated on the basis of the four determinations before the first infusion of CAP or
saline. The mean (± SEM) values between groups were compared by t-test using
PRISM software (GraphPAD, San Diego, CA, USA).
Results
Experiment 1
In Group I the effective dose of OT for stimulation of PGFM secretion
was established. OT given to gilts at the dose of 20 IU most effectively stimu-
lated PGFM release (P < 0.001 vs. baseline; Fig. 1 and Table 1). Ten IU of OT
had weaker influence (P < 0.05) and 30 IU and saline did not increase plasma
PGFM concentrations (P > 0.05). Thus, in gilts of the next groups the dose of
20 IU was used. Any of CAP doses given into uterine horns (Group II) were ef-
fective and OT (20 IU) stimulated PGFM release (P < 0.001, Fig. 1, Fig. 2, Ta-
ble 1). Oxytocin (20 IU) injected immediately after infusion of CAP at doses of
9 mg, 14 mg or 18 mg did not increase PGFM concentration (Group III; P >
0.05). When OT (20 IU) was administered 4 h, 6 h or 8 h following infusion of
9 mg CAP the post-treatment PGFM plasma level also did not exceed the base-
line (P > 0.05, Fig. 1 and Table 1).
Experiment 2
Administration of CAP diminished (P < 0.05) the height of the PGFM
peaks compared to saline infusion and tended to reduce the number of PGFM
peaks (P < 0.057; Table 2). The first PGFM peak related to the luteolytic release
of PGF2a (accepted arbitrarily as > 500 pg/ml) occurred at 122.8 ± 11.3 h and at
72.0 ± 11.8 h from the first infusion of CAP and saline, respectively, and these
data were statistically different (P < 0.03). The height, amplitude, and number of
OT peaks were the same (P > 0.05) in CAP- and in saline-treated gilts (Table 2).
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Fig. 1. Plasma concentrations of PGFM (mean ± SEM) in gilts of Experiment 1. (A)  gilts of
Group I (n = 6) received bolus injection (i.v.) of saline or OT. (B)  gilts of Group II (n = 3) were
injected into the uterine horns (UH) with CAP (2 mg4 mg  since there was no difference be-
tween treatments, data were combined) and OT (20 IU; i.v.) was administered 30 min later; in
Group III (n = 4) CAP (9 mg) was infused (30 min) into JV and OT (20 IU; i.v.) was given imme-
diately thereafter. (C)  gilts of Group IV (n = 4) received a 30-min infusion of 9 mg of CAP
at 4 h before OT (20 IU)
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Table 1
Influence of saline (2 ml) and OT (20 IU) i.v. injections and CAP (24 mg) injection into the
uterine horns (UH) 30 min before OT (20 IU), and CAP (9 mg) infusions into the jugular vein (JV)
immediately before or 4 h prior to OT (20 IU i.v.) on PGFM plasma concentrations
(pg/ml; means ± SEM) in gilts
Baseline After OT
(600 min) (060 min)
Saline (n = 6) 336 ± 30 310 ± 7
OT (n = 6) 372 ± 23a 541 ± 21b
CAP (UH) + OT (n = 3) 225 ± 22a 425 ± 32b
CAP (JV) + OT (n = 4) 446 ± 58 346 ± 41
CAP (JV) + OT 4 h later (n = 4) 483 ± 58 424 ± 41
a,bValues in the same row with different superscripts are significantly different (P < 0.001)
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Fig. 2. Plasma PGFM concentrations in an individual gilt in response to bolus injections of OT
(20 IU) into JV preceded by injection of saline or CAP (2 mg - Day 16, 3 mg - Day 17 and
4 mg - Day 18) into uterine horns
Table 2
Characterisation of PGFM and OT peaks in the saline and OT antagonist (CAP) treated gilts from
Day 12 to 20 of the oestrous cycle (mean ± SEM)
Treatment Hormone
Highest value
in peak (pg/ml)
Amplitude
(pg/ml)
No. of peaks
per gilt
No. of peaks
per 24 h
Saline PGFM 940 ± 129a 503 ± 85 14.7 ± 0.9a 1.63 ± 0.1
(n = 3) OT 30.4 ± 1.5 12.0 ± 1.3 12.7 ± 0.9 1.4 ± 0.2
CAP PGFM 663 ± 55b 402 ± 45 11.5 ± 1.3c 1.28 ± 0.1
(n = 4) OT 33.7 ± 1.4 11.4 ± 1.2 8.8 ± 1.3 1.0 ± 0.1
Means in the same column for the same hormone with different superscripts differ a,b(P < 0.05);
a,c(P < 0.057)
Treatment
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Agreement between OT and PGFM peaks was similar (P = 0.23) in CAP- and
saline-treated gilts and it was 17% and 30%, respectively. The mean concentra-
tions of P4 before luteolysis did not differ (P < 0.83) in CAP- (25.5 ± 0.4 ng/ml)
and saline- (25.0 ± 0.5 ng/ml) treated gilts. The continuous decline of plasma P4
(below 10 ng/ml) was observed at 117.8 ± 16.2 h and 99.0 ± 7.0 h from the first
infusion of CAP and saline, respectively (P < 0.39). The mean concentrations of
E2 before luteolysis did not differ (P = 0.23) in gilts treated with CAP (36.0 ±
0.9 pg/ml) and saline (42.4 ± 1.0 pg/ml). The ovaries from gilts receiving CAP
and saline were similar and they were typical of the periovulatory period of the
oestrous cycle. Eleven to 16 follicles near ovulation (Æ 0.71 cm) were ob-
served in CAP- (#25 and #32) and saline-treated gilts (#27, #28 and #34) and
corpora lutea in haemorrhagicum stage in CAP-treated gilts (#26 and #33) (Figs
3 and 4).
Discussion
Injections of OT at doses of 10 (P < 0.05) and 20 IU (P < 0.001) increased
plasma PGFM concentrations above baseline, but 30 IU was ineffective. An ex-
planation can be the age of gilts we used, since in multiparous sows 30 IU of OT
stimulated PGFM secretion (Kieborz et al., 1991; Edgerton et al., 1996). After
administration of 20 IU of OT the mean plasma concentration of OT increased
nine-fold (from 20.3 ± 2.0 pg/ml to 179.0 ± 29 pg/ml) and this high level lasted
for about one hour. It was accompanied by an increase of PGFM concentration
(r = 0.78; P = 0.0009).
The CAP infusion into JV at the dose of 9 mg suppressed PGFM secretion
when OT (20 IU) was injected 4 h later (after CAP treatment). Thus, we as-
sumed that 9 mg of CAP given every 4 h effectively blocked PGF2a release by
OT and this regimen was used in Experiment 2.
The concentration of OT receptors in swine endometrium is constant be-
tween Days 10 to 16 post-oestrus but at this time their affinity increased mark-
edly (Ludwig et al., 1998). Responsiveness to exogenous OT develops before
the onset of functional luteolysis (Days 12 to 14), but treatment with OT in-
creased PGF2a secretion on Days 14 to 18 of the cycle with maximal release of
hormone on Day 16 (Kieborz et al., 1991; Edgerton et al., 1996; this study).
Therefore, the CAP infusion in this study was started before the time of the
maximal responsiveness of OT receptors on OT (Day 12) and lasted beyond the
time of spontaneous luteolysis (Day 20). However, this did not prevent the pul-
satile release of PGFM, though the height of PGFM peaks was statistically lower
(P < 0.05) in gilts receiving CAP compared to the control. The frequency of
PGFM peaks also tended to be smaller (P = 0.057) in the CAP group. The first
luteolytic peak of PGFM occurred later in CAP-treated than in saline-treated
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Fig. 3. Concentrations of progesterone, oxytocin and PGFM in blood plasma samples collected every hour in four CAP-treated gilts between
Days 12 and 20 of the oestrous cycle. Gilts received a 30-min infusion of 9 mg CAP every 4 h
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Fig. 4. Concentrations of progesterone, oxytocin and PGFM in blood plasma samples collected
every hour in three saline-treated gilts between Days 12 and 20 of the oestrous cycle.
Gilts received a 30-min infusion of 10 ml saline every 4 h
258 KOTWICA et al.
Acta Veterinaria Hungarica 47, 1999
gilts (P = 0.03). The decrease of PGFM secretion had no influence on the initia-
tion of luteolysis. Ovaries, examined after slaughter of gilts, were similar in both
groups. Thus, the lower PGF2a secretion was sufficient to cause the luteolysis
anyway. Similar data were obtained by Rampacek et al. (1979) who could in-
duce ovulation in prepubertal gilts, though they had lower PGF2a peaks and
these peaks were observed later as compared to mature sows. Collectively, our
results indicate that OT may be the only one of the many factors which control
the initiation, quantity and duration of pulsatile PGF2a release in sows.
The uterus is known to be necessary for PGF2a release by OT, because in
hysterectomized sows OT injections did not increase plasma hormone concen-
trations (Carnahan et al., 1996). In swine endometrium, glandular epithelial cells
and luminal surface produce greater quantities of PGF2a than stromal cells
(Davis and Blair, 1993). However, in in vitro studies OT-stimulated PGF2a se-
cretion was highest from the stromal cells, much lower from glandular epithelial
cells, and the luminal surface was unresponsive to OT (Uzumcu and Mirando,
1996; Uzumcu et al., 1997). Thus, in swine OT seems to stimulate PGF2a release
from a small part of endometrial cells (stromal cells), synthesising only low
amount of PGF2a. Therefore, it is possible in our study that in CAP-infused gilts
only stromal cells (able to respond to OT) were blocked, whereas the other types
of endometrial cells were still able to produce PGF2a in spite of CAP infusion
due to the lack of OT receptors. Deficiency of CAP influence on luminal surface
(unresponsive to OT) is also suggested by results of our studies in Group II.
CAP at doses from 2 to 4 mg/gilt given directly into both uterine horns did not
suppress OT-induced PGF2a secretion.
The swine myometrium contains PGF2a during luteolysis (Stefañczyk-
Krzymowska et al., 1994). CAP can prevent myometrial contractions induced by
OT (Melin, 1993). However, it is not known if OT receptors are involved in
PGF2a release by the myometrium.
The lack of full inhibition of PGFM release by CAP in our experiment
may also be connected with the ability of the uterus to synthesise OT (Trout et
al., 1995; Boulton et al., 1996). Whether this endogenous OT can compete for
the uterine receptor and thus impair the effect of CAP may be only speculated.
The results of this study suggest the lack of involvement of OT in regu-
lating the length of oestrous cycle in gilts. In contrast to our data, exogenous OT
given on Days 10 to 16 of the cycle shortened the inter-oestrus interval by 1
2 days (Prince et al., 1995). This divergence is difficult to elucidate. Prince et al.
(1995) started to give OT on Day 10, i.e. 2 days earlier than CAP was infused in
our study. Ludwig et al. (1998) found that the secretory pathway between pro-
tein Gq and PGF2a release from endometrial cells is fully functional from
Day 10; however, PGF2a secretion after OT treatment is not stimulated before
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Day 16. Thus, the question about the mechanism of luteolysis initiation in pigs is
still open. One of the candidates in this mechanism can be P4. This hormone
seems to play an important role as a regulator of pulsatile release of PGF2a in
ewes and cattle (Ottobre et al., 1980; Lafrance and Goff, 1988). In sows that re-
ceived exogenous P4 on Days 1 to 5 after oestrus, the premature basal and OT-
induced elevation of PGFM plasma concentration was also observed (Printz et
al., 1994), although this affected neither the length of oestrous cycle nor en-
dometrial OT receptor concentration (Printz et al., 1994; Uenoyama et al., 1997).
It is suggested that the duration of P4 exposure of the porcine uterus may be im-
portant for determination of the time when luteolytic PGF2a secretion will start.
OT antagonists were used for studies on the role of OT in controlling
luteolysis in ruminants, but the results are not consistent. It prolonged the dura-
tion of the cycle, elevated P4 concentration until Day 23 post-oestrus and dimin-
ished peaks of PGF2a observed during luteolysis in ewes (Jenkin et al., 1994).
Similarly, an OT antagonist [dET2 Tyr (Et)OVT] suppressed the increase in
PGFM concentration and extended the length of the oestrous cycle in goats
(Homeida and Khalafalla, 1987). However, in cattle CAP treatment did not
change the duration of the cycle and P4 and PGFM pulsatile secretion (Kotwica
et al., 1997).
The agreement between OT and PGFM peaks in our study ranged between
17% (CAP-treated gilts) and 30% (saline-treated gilts). It is possible that sampling
at 1-h intervals may have failed to detect some hormone peaks. Supposedly, there-
fore, the correlation between OT and PGFM peaks in this study was less evident
than found in sheep (Hooper et al., 1986). On the other hand, the lower frequency
of OT peaks in CAP-treated gilts as compared to saline-treated ones was accompa-
nied with the lower frequency of PGFM surges. Recent studies by Walker et al.
(1997) have revealed in ewes that pulses of PGF2a which were linked to OT secre-
tion ranged from 36% to 53%. These pulses had a longer duration and a higher
amplitude than pulses that were not linked. In our study, peaks of PGFM were
lower and less frequent in CAP-infused gilts. This confirms that OT affects the
shape of the luteolytic PGF2a peaks in sows and ewes.
In conclusion, data obtained in this study show that OT may be involved in
the control of pulsatile release of PGF2a at luteolysis in sows. However, its role is
not mandatory, since the blockade of OT uterine receptors diminished only the
height and frequency of PGFM peaks. Moreover, the blockade of OT receptors
neither prevents luteolysis nor changes the duration of the oestrous cycle in swine.
260 KOTWICA et al.
Acta Veterinaria Hungarica 47, 1999
Acknowledgements
The authors are grateful to Dr P. Melin (Ferring AB, Malmo, Sweden) and Dr W.
J. Silvia (University of Kentucky, Lexington, USA) for providing CAP-581 and PGFM
antiserum, respectively. This work was supported by the National Research Council
(Grant No 5 P06D 017 10).
References
Boulton, M. J., McGrath, T. J., Goode, J. A., Broad, K. D. and Gilbert, C. L. (1996): Changes in
content of mRNA encoding oxytocin in the pig uterus during the oestrous cycle, preg-
nancy, at parturition and in lactational anoestrous. J. Reprod. Fert. 108, 219227.
Carnahan, K. G., Prince, B. C. and Mirando, M. A. (1996): Exogenous oxytocin stimulates uterine se-
cretion of prostaglandin F2a in cyclic and early pregnant swine. Biol. Reprod. 55, 838843.
Davis, D. L. and Blair, R. M. (1993): Studies of uterine secretions and products of primary cultures
of endometrial cells in pigs. J. Reprod. Fert. Suppl. 48, 143155.
Dziadkowiec, I., Danilczyk, H. and Rembiesa, R. (1982): Biosynthesis of progesterone in the pla-
centa of rats (in Polish). Endocrinol. Pol. 33, 46.
Edgerton, L. A., Kaminski, M. A. and Silvia, W. J. (1996): Changes in uterine secretion of prosta-
glandin F2a in response to oxytocin during the estrous cycle, early pregnancy, and estro-
gen-induced pseudopregnancy in swine. Biol. Reprod. 55, 657662.
Gleeson, A. R., Thorburn, G. D. and Cox, R. J. (1974): Prostaglandin F concentrations in the
utero-ovarian venous plasma of the sow during the late luteal phase of the oestrous cycle.
Prostaglandins 5, 521529.
Homanics, G. E. and Silvia, W. J. (1988): Effects of progesterone and estradiol 17b on uterine se-
cretion of prostaglandin F2a in response to oxytocin in ovariectomized ewes. Biol. Reprod.
38, 804811.
Homeida, A. M. and Khalafalla, A. E. (1987): Effects of oxytocin-antagonist injections on luteal
regression in the goat. Br. J. Pharmacol. 90, 281284.
Hooper, S. B., Watkins, W. B. and Thornburn, G. D. (1986): Oxytocin, oxytocin-associated neuro-
physins, and prostaglandin F2a concentrations in the utero-ovarian vein of pregnant and
nonpregnant sheep. Endocrinology 119, 25902597.
Hotchkiss, J., Atkinson, L. E. and Knobil, E. (1971): Time course of serum estrogen and luteiniz-
ing hormone (LH) concentrations during the menstrual cycle of the rhesus monkey. Endo-
crinology 89, 177183.
Jenkin, G., Buttress, D. and Harding, R. (1994): Oxytocin receptor blockade and prostaglandin re-
lease in late pregnant sheep. Eur. J. Obstet. Gynecol. 53, 16.
Kieborz, K. R., Silvia, W. J. and Edgerton, L. A. (1991): Changes in secretion of prostaglandin F2a
and luteal secretion of progesterone in response to oxytocin during the porcine estrous cy-
cle. Biol. Reprod. 45, 950954.
Kotwica, G., Dusza, L., Ciereszko, R., Okrasa, S. and Schams, D. (1990): Oxytocin plasma levels
during spontaneous and cloprostenol-induced luteolysis in sows. Anim. Reprod. Sci. 22,
109119.
Kotwica, J. and Skarzynski, D. (1993): Influence of oxytocin removal from corpus luteum on se-
cretory function and duration of the estrous cycle in cattle. J. Reprod. Fert. 97, 411417.
Kotwica, J., Krzymowski, T. and Debek, J. (1978): Cannulation of veins in pig for endocrinous
studies (in Polish). Med. Wet. 2, 118120.
EFFECT OF OXYTOCIN ANTAGONIST ON LUTEOLYSIS IN SOWS 261
Acta Veterinaria Hungarica 47, 1999
Kotwica, J., Skarzynski, D., Bogacki, M., Melin, P. and Starostka, B. (1997): The use of an oxyto-
cin antagonist to study the function of ovarian oxytocin during luteolysis in cattle. Therio-
genology 48, 12871299.
Lafrance, M. and Goff, A. K. (1988): Effects of progesterone and estradiol 17 b on oxytocin-
induced release of prostaglandin F in heifers. J. Reprod. Fert. 82, 429436.
Lopez-Bernal, A., Phipps, S. L., Rosevear, S. K. and Turnbull, A. C. (1989): Mechanism of action
of the oxytocin antagonist-1-deamino-2-D-Tyr(oET)-4-Thr-8-Orn-oxytocin. Br. J. Obstet.
Gynaecol. 96, 11081110.
Ludwig, T. E., Sun, Bee-Chun, Carnahan, K. G., Uzumcu, M., Yelich, J. V., Geisert, T. E. and Mi-
rando, M. A. (1998): Endometrial responsiveness to oxytocin during diestrus and early
pregnancy in pigs is not controlled solely by changes in oxytocin receptor population den-
sity. Biol. Reprod. 58, 769777.
Melin, P. (1993): Oxytocin antagonists in preterm labour and delivery. Baillières Clinical Obster-
tics and Gynaecology. Baillière Tindall, LondonPhiladelphia, 7, pp. 577600.
Mirando, M. A., Prince, B. C., Tysseling, K. A., Carnahan, K. G., Ludwig, T. E., Hoagland, T. A.
and Crain, R. C. (1995): A proposed role for oxytocin in regulation of endometrial prosta-
glandin F2a secretion during luteolysis in swine. Oxytocin. In: Ivell, R. and Russell, J. (eds)
Plenum Press, New York, pp. 421433.
Mirando, M. A., Uzumcu, M., Carnahan, K. G. and Ludwig, T. E. (1996): A role for oxytocin
during luteolysis and early pregnancy in swine. Reprod. Dom. Anim. 31, 455461.
Moeljono, M. P. E., Thatcher, W. W., Bazer, F. W., Frank, M., Owens, L. J. and Wilcox, C. J.
(1977): A study of prostaglandin F2a as the luteolysin in swine: II Characterisation and
comparison of prostaglandin F, estrogens and progestin concentrations in utero-ovarian
vein plasma of non-pregnant and pregnant gilts. Prostaglandins 14, 543555.
Okano, A., Okuda, K., Takahashi, M. and Schams, D. (1996): Oxytocin receptors in porcine en-
dometrium during the estrous cycle and early pregnancy. Anim. Reprod. Sci. 41, 6170.
Ottobre, J. S., Lewis, G. S., Thayne, W. V. and Inskeep, E. K. (1980): Mechanism by which pro-
gesterone shortens the oestrous cycle of the ewe. Biol. Reprod. 23, 10461053.
Prince, B. C., Mirando, M. A., Becker, W. C. and Hostetler, C. E. (1995): Exogenous oxytocin de-
creases interestrous interval of cyclic gilts. J. Anim. Sci. 73, 36813686.
Printz, V. J., Silvia, W. J. and Edgerton, L. A. (1994): Changes in peripheral concentrations of
13,14-dihydro-15-keto-prostaglandin F2a induced by progesterone in swine. J. Anim. Sci.
72, 459463.
Rampacek, G. B., Krealing, R. R., Kiser, T. E., Barb, C. R. and Benyshek, L. L. (1979): Prosta-
glandin F concentrations in utero-ovarian vein plasma of prepubertal and mature gilts.
Prostaglandins 18, 247255.
Schams, D., Schmidt-Polex, B. and Kruse, V. (1979): Oxytocin determination by radioimmunoas-
say in cattle. Acta Endocrinol. 92, 258270.
Schneider, T. M., Tilton, J. E., Okrasa, S. and Mah, J. (1983): The effect of intrauterine infusions
of prostaglandin E2 on luteal function in nonpregnant gilts. Theriogenology 20, 509520.
Shille, V. M., Karlbom, I., Einarsson, S., Larson, K., Kindahl, H. and Edqvist, L-E. (1979): Con-
centrations of progesterone and 15-keto-13,14-dihydroprostaglandin F2a in peripheral
plasma during the oestrous cycle and early pregnancy in gilts. Zbl. Vet. Med. 26, 169181.
Stefañczyk-Krzymowska, S., Szafranska, B., Kaminski, T. and Krzymowski, T. (1994): Total con-
tent of prostaglandin F2a in the endometrium and myometrium from various sections of the
porcine uterine horn during the estrous cycle. Prostaglandins 48, 99108.
Szafranska, B. and Tilton, J. E. (1993): Prolactin as a luteotrophin during late pregnancy in pigs. J.
Reprod. Fert. 98, 643648.
262 KOTWICA et al.
Acta Veterinaria Hungarica 47, 1999
Trout, W. E., Smith G. W., Gentry, P. C., Galvin, J. M. and Keisler, D. H. (1995): Oxytocin secre-
tion by the endometrium of the pig during maternal recognition of pregnancy. Biol. Re-
prod. 52, Suppl. 1, Abstr. 189.
Tysseling, K. A., Uzumcu, M., Hoagland, T. A., Crain, R. C. and Mirando, M. A. (1996): The role
of phosphoinositide-derived second messengers in oxytocin-stimulated prostaglandin F2a
release from endometrium of pigs. Dom. Anim. Endocrinol. 13, 411420.
Uenoyama, Y., Hattori, S-J., Miyake, M. and Okuda, K. (1997): Up-regulation of oxytocin receptors
in porcine endometrium by adenosine 35monophosphate. Biol. Reprod. 57, 723728.
Uzumcu, M. and Mirando, M. A. (1996): Differential phosphoinositide hydrolysis and prostaglan-
din F2a response to luminal epithelial, glandular epithelial and stromal cells from en-
dometrium of cyclic gilts to oxytocin. Biol. Reprod. 54, Suppl. 1, Abstr. 255.
Uzumcu, M., Carnahan, K. G., Ludwig, T. E. and Mirando, M. A. (1997): Oxytocin-stimulated
phosphoinositide hydrolysis and prostaglandin F2a secretion by luminal epithelial, glandu-
lar epithelial and stromal cells from pig endometrium II. Response of cyclic, pregnant and
pseudo-pregnant pigs on Day 16 post-oestrus. Biol. Reprod. 56, Suppl. 1, Abstr. 200.
Walker, D. L., Weston, P. G. and Hixon, J. E. (1997): Influence of estradiol and progesterone
withdrawal on the secretion of and the temporal correlation between pulses of oxytocin and
prostaglandin F2a in ewes. Biol. Reprod. 56, 12281238.
Whiteaker, S., Mirando, M. A., Becker, W. C. and Hostetler, C. E. (1994): Detection of functional
oxytocin receptors on endometrium of pigs. Biol. Reprod. 51, 9298.
Whiteaker, S. S., Mirando, M. A., Becker, W. C. and Peters, D. N. (1995): Relationship between
phosphoinositide hydrolysis and prostaglandin F2a secretion in vitro from endometrium of
cyclic pigs on day 15 postestrus. Dom. Anim. Endocrinol. 12, 95104.
